Service Engineer James Hanson has just been to Southampton General Hospital and performed a successful dual turbo upgrade and full service on a Sercon ABCA system being used by Dr Paul Afolabi in the Mass Spectrometry Lab.
Dr Paul Afolabi will use the Sercon ABCA instrument in his work on a Pancreatic Cancer diagnostic technique using Isotopically labelled fatty acids. A patient’s breath is analysed for isotopic abundance of C13 in CO2 before the fatty acids are ingested, with another beath sample being taken and analysed a few hours after the fatty acid ingestion. The difference or change in isotopic abundance of C13 between the 2 samples can then be interpreted as a positive or negative result for Pancreatic Cancer. This is a non-invasive and rapid diagnostic technique for the 5th highest cancer related cause of death in the UK.
Sercon’s ABCA system is CE/IVD Certified in conjunction with ISO13485 for medical devices and the only dedicated H Pylori IRMS instrument to be FDA approved.
For those interested in more detail about Dr Afolabi’s research, here is a link to the research paper – https://bmjopen.bmj.com/content/bmjopen/12/2/e057271.full.pdf